Yee Chao

Fu Jen Catholic University — Taiwan

Medicine · Health Sciences

64h-index23.1kcitations488works23.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(128), Gastric Cancer Management and Outcomes(121), Pancreatic and Hepatic Oncology Research(75), Cholangiocarcinoma and Gallbladder Cancer Studies(71), Cancer Immunotherapy and Biomarkers(65)

Publications485 total

Establishment of a Flow Cytometry Protocol for Binarily Detecting Circulating Tumor Cells with EGFR Mutation
Diseases·2025Open Access
Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma
Clinical Cancer Research·2025Open Access
Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning
BMC Cancer·2025Open Access
Effects of Organizational and Behavioral Reactions of Virtual Crowds on Users' Visual Attention in a Stressful Virtual Reality Simulation
2025
Precision Oncology in Duodenal Adenocarcinoma: A Case of Metastatic BRAF V600E-mutant Disease Treated with Encorafenib, Cetuximab, Chemotherapy, and Immunotherapy
Journal of Cancer Research and Practice·2025Open Access
Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: a case report
Frontiers in Oncology·2025Open Access
Detecting HER2-positive circulating tumor cells in gastric cancer using a flow cytometry-based approach
Frontiers in Medicine·2025Open Access
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-Line Immunotherapy: A Phase II Clinical Study
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Real-world outcomes of selective internal radiation therapy with <sup>90</sup> Y resin microspheres in HCC/mCRC: RESIN registry Asia
Future Oncology·2025· 1 cited
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial
Hepatology·2025· 8 citedOpen Access
FRI-133 Immunoprofiling-based machine learning model predicts outcomes to pembrolizumab plus lenvatinib in patients with unresectable hepatocellular carcinoma
Journal of Hepatology·2025
Real-world efficacy of cabozantinib alone or in combination with ICIs in heavily pretreated hepatocellular carcinoma: potential role of AXL and MET expression
Annals of Hepatology·2025· 3 citedOpen Access
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors
The Oncologist·2025Open Access
Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis
BMC Cancer·2025Open Access
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
BMC Cancer·2025· 7 citedOpen Access
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
The Lancet·2025· 153 citedOpen Access
Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosis
ESMO Gastrointestinal Oncology·2024Open Access
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas
Alimentary Pharmacology & Therapeutics·2024· 12 citedOpen Access
A flexible, sustainable, and deep learning-assisted triboelectric patch for self-powered interactive sensing and wound healing applications
Nano Energy·2024· 15 cited
Effects of Organizational and Behavioral Reactions of Virtual Crowds on Users’ Affect and Behavior in a Simulated Stressful Situation
2024· 3 cited
page 1 of 25Next →

Frequent Co-authors

Yoon‐Koo Kang(10), Masatoshi Kudo(9), Ann‐Lii Cheng(8), Chih‐Hung Hsu(7), Hyun Cheol Chung(6), Ho Yeong Lim(6), Chung‐Pin Li(6), Yi‐Hsiang Huang(6), Ken Kato(5), Jen‐Shi Chen(5), Won Ki Kang(5), Sang Cheul Oh(5), Keun‐Wook Lee(5), Li‐Tzong Chen(5), Eric Van Cutsem(5), Stephen L. Chan(5), Chiun Hsu(5), Ming‐Huang Chen(5), Chien‐Wei Su(5), Chien‐Fu Hung(5)